Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD2 in the kidney Naohiro TakahashiHiroaki KikuchiEisei Sohara Original article Open access 17 February 2021 Pages: 445 - 455
Renal prognoses by different target hemoglobin levels achieved by epoetin beta pegol dosing to chronic kidney disease patients with hyporesponsive anemia to erythropoiesis-stimulating agent: a multicenter open-label randomized controlled study Kazuhiko TsuruyaTerumasa HayashiRADIANCE-CKD Study Investigators Original article 07 January 2021 Pages: 456 - 466
Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease Shigeo HorieSatoru MutoTatsuki Ibuki Original article Open access 20 January 2021 Pages: 467 - 478
Incidence and risk factors of acute kidney injury, and its effect on mortality among Japanese patients receiving immune check point inhibitors: a single-center observational study Yoshinosuke ShimamuraShota WatanabeHideki Takizawa Original article 20 January 2021 Pages: 479 - 487
Effects of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A expression in glomerular basement membranes on treatment response and renal outcome in membranous nephropathy Hasan H. YeterIpek Isik GonulGalip Guz Original article 18 January 2021 Pages: 488 - 500
Improving hepatitis B vaccination rates for advanced chronic kidney disease patients: a quality improvement initiative Priyanka MysoreRoaa M. KhinkarMallika L. Mendu Original article 07 January 2021 Pages: 501 - 508
A cross-sectional study in patients with IgA nephropathy of correlations between clinical data and pathological findings at the time of renal biopsy: a Japanese prospective cohort study Chisako KamanoAkira ShimizuThe Japan IgA nephropathy prospective cohort Study Group Original article 17 February 2021 Pages: 509 - 521
Association of serum lncRNA H19 expression with inflammatory and oxidative stress markers and routine biochemical parameters in chronic kidney disease Hamza Malik OkuyanSerdar DoganFaruk Hilmi Turgut Original article 06 February 2021 Pages: 522 - 530
Valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant recipients: a single-center experience Takaya IidaKenichiro MiuraMotoshi Hattori Original article 27 January 2021 Pages: 531 - 536
The importance of kidney volume as a marker in the assessment of living-donor kidney transplantation in Japan Makoto TsujitaNorihiko GotoYoshihiko Watarai Original article 07 January 2021 Pages: 537 - 544
Early cardiovascular events and cardiovascular death after renal transplantation: role of pretransplant risk factors Jose Jayme G. De LimaLuis Henrique W. GowdakLuiz A. Bortolotto Original article 27 January 2021 Pages: 545 - 553
Association between urine pH and risk of contrast-associated acute kidney injury among patients after emergency percutaneous coronary intervention: a V-shape relationship? Hanchuan ChenChen HeYansong Guo Original article Open access 11 January 2021 Pages: 554 - 561
Hematuria, bone health, and cardiovascular mortality Minako WakasugiJunichiro James Kazama Letter to the editor 07 January 2021 Pages: 562 - 563
Correction to: Functional analysis of suspected splicing variants in CLCN5 gene in Dent disease 1 Tomohiko InoueChina NaganoKandai Nozu Correction Open access 15 March 2021 Pages: 564 - 564
Correction to: Genome-wide association study identifies new loci for albuminuria in the Japanese population Hiroshi OkudaKoji OkamotoTadashi Ishii Correction Open access 27 March 2021 Pages: 565 - 565